Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(U)-binding-splicing factor 60 (PUF60) is an RNA- and DNA-binding protein involved in pre-mRNA splicing and transcriptional regulation[1][3][4][7]. It contains two RNA recognition motifs and a U2AF homology motif, bearing structural similarity to U2AF65 but lacking its N-terminal RS domain[3]. PUF60 promotes or modulates splicing at weak 3' splice sites, plays roles in alternative splicing, and represses transcription of the MYC oncogene by forming a complex with FUSE and FUSE-binding protein[1][5][7]. Functionally, it cooperates with other splicing factors, especially U2AF2, and impacts the processing of key transcripts in both physiological and disease states such as cancer and developmental syndromes (e.g., Verheij syndrome)[1][3][5][7]. PUF60 also acts as a regulator of transcription and post-transcriptional processes during hepatitis B virus replication[5]. Loss-of-function mutations in PUF60 cause multisystem developmental disorders and intellectual disability[7]. No approved or investigational drugs are known to directly target PUF60 as of this writing, and it is not a standard therapeutic target, but is implicated in the molecular pathology of human diseases and may serve as a biomarker for diagnostic or research purposes[7].
Modulation of alternative and constitutive splicing; Regulation of gene transcription (e.g., MYC repression, interaction with FUSE-binding protein); Cooperates with U2AF2 (U2AF65) in splicing site recognition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(U)-binding-splicing factor 60 (PUF60).